Showing 118 of 118on this page. Filters & sort apply to loaded results; URL updates for sharing.118 of 118 on this page
Alnylam Announces FDA Approval of AMVUTTRA™ (vutrisiran), an RNAi ...
罕见遗传病药物Amvuttra和Onpattro有什么区别？-香港济民药业
RNAi治疗药物Amvuttra在美获批新适应症，用于治疗ATTR-CM-上市-医保-临床适应症-香港济民药业
Geriatrics News | MedPage Today
DailyMed - AMVUTTRA- vutrisiran injection
Drug Hunter - Articles Archives
Alnylam Announces FDA Approval of AMVUTTRA® (vutrisiran), the First ...
Amvuttra (vutrisiran) dosing, indications, interactions, adverse ...
ATTR-CM Drugs: TTR Stabilizers vs. Gene Silencer Treatments
Vutrisiran in Transthyretin Amyloidosis with Cardiomyopathy | New ...
siRNA Therapeutics for the Treatment of Hereditary Diseases and Other ...
Amvuttra(Vutrisiran)说明书-价格-功效与作用-副作用-香港济民药业
Alnylam® Pharmaceuticals
FDA Approves Vutrisiran (AMVUTTRA) for ATTR-CM
Amvuttra: The First Quarterly Injection for Treating hATTR Amyloidosis
Amvuttra
Amvuttra | Australian Commission on Safety and Quality in Health Care
RNAi疗法！Amvuttra(Vutrisiran)中文说明书-价格-适应症-不良反应及注意事项 -香港济民药业
Alnylam Pharmaceuticals Press Release | Jun 09, 2025 | Alnylam Receives ...
1718594179401119.png
AMVUTTRA (vutrisiran) maintenant disponible en pharmacie d’officine ...
Amvuttra (vutrisiran) - Dosing, PA Forms & Info (2026)
Alnylam Receives European Commission Approval for AMVUTTRA® (vutrisiran ...
Amvuttra - Vutrisiran 25 mg/0.5 mL injection, 0.5 mL syringe – Price ...
Amvuttra（Vutrisiran）药品介绍高清完整视频在线观看-香港济民药业
Vutrisiran (Amvuttra) bei Amyloidose | Gesundheitsinformation.de
Special Report: 2022 Neurology Drug & Device Approvals
Kayla Yup — Former Reporting Intern at The Wall Street Journal
Amvuttra Approved for Polyneuropathy of Hereditary Transthyretin ...
Amvuttra (vutrisiran): Uses, Side Effects, Dosage & More - GoodRx
How AMVUTTRA Works | AMVUTTRA® (vutrisiran) HCP
Dosing & Administration | AMVUTTRA® (vutrisiran)
Home | AMVUTTRA™ (vutrisiran)
Amvuttra: Package Insert / Prescribing Information / MOA
El Gobierno de España ha aprobado la financiación de Amvuttra para el ...
How AMVUTTRA Works | AMVUTTRA® (vutrisiran)
Understanding ATTR-CM and hATTR-PN | AMVUTTRA® (vutrisiran)
AMVUTTRA : un nouveau médicament pour l'amylose héréditaire à ...
Amvuttra (Vutrisiran Injection): Side Effects, Uses, Dosage ...
Amvuttra (vutrisiran)- polyneuropathy of hereditary transthyretin ...
FDA approves vutrisiran for ATTR amyloidosis with cardiomyopathy
How long has Amvuttra (vutrisiran) been available for the treatment of ...
How AMVUTTRA works | AMVUTTRA® (vutrisiran)
Amvuttra injection how to use: Uses, Dosage, Side Effects ...
Full article: Efficacy and safety of vutrisiran for patients with ...
식약처, TTR-FAP 치료제 ‘암부트라’ 국내 허가 - 헬스코리아뉴스
La Comisión Europea aprueba AMVUTTRA® para el tratamiento de la ...
Dosing & Administration | AMVUTTRA® (vutrisiran) HCP
Amvuttra Inj Lös Fertspr 0.5 ml | Online bestellen
European Commission Approves Alnylam's AMVUTTRA for ATTR Amyloidosis ...
Amvuttra 2026 Prices, Coupons & Savings Tips - GoodRx
盘点 | 2022年欧洲EMA批准药物 - 知乎
How AMVUTTRA™ (vutrisiran) Works | AMVUTTRA™ (vutrisiran)
Should a patient with hereditary transthyretin-mediated amyloidosis ...
Hypertrophic - The European Commission Approves Alnylam's AMVUTTRA as ...
Newly FDA Approved AMVUTTRA™ for Treatment of hATTR Amyloidosis with ...
Amvuttra - Thuốc mới điều trị bệnh đa thần kinh tích tụ amyloid do đột ...
HELIOS-B Study Design | AMVUTTRA® (vutrisiran) HCP
Taking AMVUTTRA | AMVUTTRA® (vutrisiran)
Guides & Resources | AMVUTTRA® (vutrisiran)
How AMVUTTRA Was Studied | AMVUTTRA® (vutrisiran)
HELIOS-B Efficacy | AMVUTTRA® (vutrisiran) HCP
Alnylam Pharmaceuticals, Inc. (ALNY) Discusses Progress and Strategy in ...
Amvuttra (Vutrisiran) - Rare Disease Advisor
RNAi治疗药物Amvuttra (vutrisiran)在美获批用于治疗ATTR-CM - 知乎
AMVUTTRA- vutrisiran injection
dailypharmkorea
Resources | AMVUTTRA® (vutrisiran) HCP
2024年Q1: 值得期待的Ⅲ期临床读数及PDUFA医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Amvuttra, médicament orphelin dans l’amylose héréditaire à transthyrétine
European Commission approved Alnylam’s AMVUTTRA, an RNAi therapeutic ...
Alnylam宣布siRNA新药vutrisiran获欧盟批准上市医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Onpattro vs. Amvuttra for hATTR Amyloidosis: 7 Differences ...
Alnylam大涨33%，siRNA药物vutrisiran治疗ATTR-CM大获成功医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
作用機序 | アムヴトラ.jp
Amvuttra(Vutrisiran)的适应症,功效与作用,用法用量-肿瘤药品网
Amvuttra (Vutrisiran) for FAP | Amyloidosis News Today
Amvuttra (vutrisiran) for ATTR-CM | Amyloidosis News Today
TTRadeoffs: Patients, Prescribers, Payors, and Prior Auths
Polish health technology assessment agency publishes Amvuttra ...
Amvuttra (Vutrisiran) Injection: Comprehensive Patient Guide
Pharma Invest - PharmTech Archive
Amvuttra APV FOCUS GROUP DRUG DELIVERY
-drugs-ttr-stabilizers-vs-gene-silencers-seo-graphics.png?sfvrsn=f0f8309_3){kind=spacer}
